Cancer incidence in systemic sclerosis: Meta-analysis of population-based cohort studies

Akira Onishi, Daisuke Sugiyama, Shunichi Kumagai, Akio Morinobu

Research output: Contribution to journalArticle

75 Citations (Scopus)

Abstract

Objective To examine cancer incidence in patients with systemic sclerosis (SSc) through a meta-analysis of population-based cohort studies. Methods Five different databases (Medline, Scopus, CINAHL [Cumulative Index to Nursing and Allied Health Literature], Web of Science, and Cochrane Collaboration) were searched for articles published between January 1966 and May 2012; review articles and the reference lists from the articles that resulted from the search were also evaluated. Population-based cohort studies with data relevant to the determination of cancer risk in patients with SSc were included. All articles that met strict inclusion criteria were analyzed for data on population size, time of followup, and observed-to-expected cancer ratios, also known as standardized incidence ratios (SIRs). Results Six articles met criteria and were included in the meta-analysis. The pooled SIR for the incidence of cancer overall was 1.41 (95% confidence interval [95% CI] 1.18-1.68), and significant heterogeneity was observed as a consequence of variability in the participants, outcome, study design, and risk of bias among the studies. Men had a significantly higher pooled SIR (1.85 [95% CI 1.49-2.31]) than women (SIR 1.33 [95% CI 1.18-1.49]) (P < 0.01), and stratification for sex eliminated heterogeneity, which indicates that variability among the studies greatly contributed to differences between the sexes. There were no differences between limited cutaneous SSc and diffuse cutaneous SSc (P = 0.77). Significant increases were observed in the risk of cancer of the lung, liver, hematologic system, and bladder, as well as of non-Hodgkin's lymphoma and leukemia. Conclusion SSc is associated with an increased risk of cancer, particularly lung, liver, hematologic, and bladder cancers, although absolute risk is relatively low. Men with SSc have a higher risk of developing cancer than women.

Original languageEnglish
Pages (from-to)1913-1921
Number of pages9
JournalArthritis and Rheumatism
Volume65
Issue number7
DOIs
Publication statusPublished - 2013 Jul

Fingerprint

Systemic Scleroderma
Meta-Analysis
Cohort Studies
Incidence
Population
Neoplasms
Confidence Intervals
Liver Neoplasms
Lung Neoplasms
Diffuse Scleroderma
Population Density
Urinary Bladder Neoplasms
Sex Characteristics
Non-Hodgkin's Lymphoma
Leukemia
Urinary Bladder
Nursing
Outcome Assessment (Health Care)
Databases
Skin

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Rheumatology
  • Pharmacology (medical)

Cite this

Cancer incidence in systemic sclerosis : Meta-analysis of population-based cohort studies. / Onishi, Akira; Sugiyama, Daisuke; Kumagai, Shunichi; Morinobu, Akio.

In: Arthritis and Rheumatism, Vol. 65, No. 7, 07.2013, p. 1913-1921.

Research output: Contribution to journalArticle

Onishi, Akira ; Sugiyama, Daisuke ; Kumagai, Shunichi ; Morinobu, Akio. / Cancer incidence in systemic sclerosis : Meta-analysis of population-based cohort studies. In: Arthritis and Rheumatism. 2013 ; Vol. 65, No. 7. pp. 1913-1921.
@article{d467fb26659a4db58af8ce0d03786669,
title = "Cancer incidence in systemic sclerosis: Meta-analysis of population-based cohort studies",
abstract = "Objective To examine cancer incidence in patients with systemic sclerosis (SSc) through a meta-analysis of population-based cohort studies. Methods Five different databases (Medline, Scopus, CINAHL [Cumulative Index to Nursing and Allied Health Literature], Web of Science, and Cochrane Collaboration) were searched for articles published between January 1966 and May 2012; review articles and the reference lists from the articles that resulted from the search were also evaluated. Population-based cohort studies with data relevant to the determination of cancer risk in patients with SSc were included. All articles that met strict inclusion criteria were analyzed for data on population size, time of followup, and observed-to-expected cancer ratios, also known as standardized incidence ratios (SIRs). Results Six articles met criteria and were included in the meta-analysis. The pooled SIR for the incidence of cancer overall was 1.41 (95{\%} confidence interval [95{\%} CI] 1.18-1.68), and significant heterogeneity was observed as a consequence of variability in the participants, outcome, study design, and risk of bias among the studies. Men had a significantly higher pooled SIR (1.85 [95{\%} CI 1.49-2.31]) than women (SIR 1.33 [95{\%} CI 1.18-1.49]) (P < 0.01), and stratification for sex eliminated heterogeneity, which indicates that variability among the studies greatly contributed to differences between the sexes. There were no differences between limited cutaneous SSc and diffuse cutaneous SSc (P = 0.77). Significant increases were observed in the risk of cancer of the lung, liver, hematologic system, and bladder, as well as of non-Hodgkin's lymphoma and leukemia. Conclusion SSc is associated with an increased risk of cancer, particularly lung, liver, hematologic, and bladder cancers, although absolute risk is relatively low. Men with SSc have a higher risk of developing cancer than women.",
author = "Akira Onishi and Daisuke Sugiyama and Shunichi Kumagai and Akio Morinobu",
year = "2013",
month = "7",
doi = "10.1002/art.37969",
language = "English",
volume = "65",
pages = "1913--1921",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "7",

}

TY - JOUR

T1 - Cancer incidence in systemic sclerosis

T2 - Meta-analysis of population-based cohort studies

AU - Onishi, Akira

AU - Sugiyama, Daisuke

AU - Kumagai, Shunichi

AU - Morinobu, Akio

PY - 2013/7

Y1 - 2013/7

N2 - Objective To examine cancer incidence in patients with systemic sclerosis (SSc) through a meta-analysis of population-based cohort studies. Methods Five different databases (Medline, Scopus, CINAHL [Cumulative Index to Nursing and Allied Health Literature], Web of Science, and Cochrane Collaboration) were searched for articles published between January 1966 and May 2012; review articles and the reference lists from the articles that resulted from the search were also evaluated. Population-based cohort studies with data relevant to the determination of cancer risk in patients with SSc were included. All articles that met strict inclusion criteria were analyzed for data on population size, time of followup, and observed-to-expected cancer ratios, also known as standardized incidence ratios (SIRs). Results Six articles met criteria and were included in the meta-analysis. The pooled SIR for the incidence of cancer overall was 1.41 (95% confidence interval [95% CI] 1.18-1.68), and significant heterogeneity was observed as a consequence of variability in the participants, outcome, study design, and risk of bias among the studies. Men had a significantly higher pooled SIR (1.85 [95% CI 1.49-2.31]) than women (SIR 1.33 [95% CI 1.18-1.49]) (P < 0.01), and stratification for sex eliminated heterogeneity, which indicates that variability among the studies greatly contributed to differences between the sexes. There were no differences between limited cutaneous SSc and diffuse cutaneous SSc (P = 0.77). Significant increases were observed in the risk of cancer of the lung, liver, hematologic system, and bladder, as well as of non-Hodgkin's lymphoma and leukemia. Conclusion SSc is associated with an increased risk of cancer, particularly lung, liver, hematologic, and bladder cancers, although absolute risk is relatively low. Men with SSc have a higher risk of developing cancer than women.

AB - Objective To examine cancer incidence in patients with systemic sclerosis (SSc) through a meta-analysis of population-based cohort studies. Methods Five different databases (Medline, Scopus, CINAHL [Cumulative Index to Nursing and Allied Health Literature], Web of Science, and Cochrane Collaboration) were searched for articles published between January 1966 and May 2012; review articles and the reference lists from the articles that resulted from the search were also evaluated. Population-based cohort studies with data relevant to the determination of cancer risk in patients with SSc were included. All articles that met strict inclusion criteria were analyzed for data on population size, time of followup, and observed-to-expected cancer ratios, also known as standardized incidence ratios (SIRs). Results Six articles met criteria and were included in the meta-analysis. The pooled SIR for the incidence of cancer overall was 1.41 (95% confidence interval [95% CI] 1.18-1.68), and significant heterogeneity was observed as a consequence of variability in the participants, outcome, study design, and risk of bias among the studies. Men had a significantly higher pooled SIR (1.85 [95% CI 1.49-2.31]) than women (SIR 1.33 [95% CI 1.18-1.49]) (P < 0.01), and stratification for sex eliminated heterogeneity, which indicates that variability among the studies greatly contributed to differences between the sexes. There were no differences between limited cutaneous SSc and diffuse cutaneous SSc (P = 0.77). Significant increases were observed in the risk of cancer of the lung, liver, hematologic system, and bladder, as well as of non-Hodgkin's lymphoma and leukemia. Conclusion SSc is associated with an increased risk of cancer, particularly lung, liver, hematologic, and bladder cancers, although absolute risk is relatively low. Men with SSc have a higher risk of developing cancer than women.

UR - http://www.scopus.com/inward/record.url?scp=84879848593&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879848593&partnerID=8YFLogxK

U2 - 10.1002/art.37969

DO - 10.1002/art.37969

M3 - Article

C2 - 23576072

AN - SCOPUS:84879848593

VL - 65

SP - 1913

EP - 1921

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 7

ER -